Stoke Therapeutics (STOK) Asset Utilization Ratio (2022 - 2026)

Stoke Therapeutics has reported Asset Utilization Ratio for 5 years, with the latest figure at 0.07 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 86.77% year-over-year to 0.07; the trailing twelve-month figure through Mar 2026 stood at 0.07 (down 86.77% YoY), and the FY2025 full-year result was 0.53, up 265.51% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.07, down from 0.47 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.56 in Q1 2025, with the low at 0.05 in Q4 2022.
• Average Asset Utilization Ratio over 5 years is 0.2, with a median of 0.06 recorded in 2024.
• Year-over-year, Asset Utilization Ratio jumped 891.2% in 2025 and tumbled 86.77% in 2026.
• Tracing STOK's Asset Utilization Ratio over 5 years: stood at 0.05 in 2022, then increased by 26.28% to 0.06 in 2023, then jumped by 120.48% to 0.13 in 2024, then jumped by 265.97% to 0.47 in 2025, then sank by 84.28% to 0.07 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.07 (Q1 2026), 0.47 (Q4 2025), and 0.55 (Q3 2025), per Business Quant data.

Peer Comparison